Home » Topics » Regulatory

Regulatory
RSS

Prolia obtains marketing authorization in E.U.

May 31, 2010

FDA approves Vimovo delayed-release tablets for arthritis patients

May 3, 2010

Dendreon receives FDA approval for Provenge for castrate-resistant prostate cancer

April 30, 2010

Takeda obtains five NDA approvals in Japan

April 20, 2010

Diquas ophthalmic solution approved in Japan for dry eye treatment

April 19, 2010

EMA approves combination of Xeloda and oxaliplatin for adjuvant treatment of early colon cancer

March 30, 2010

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

March 24, 2010

FDA approves Somaxon's Silenor for treatment of insomnia

March 19, 2010

FDA approves 5-day dosing of Eisai's Dacogen for MDS

March 15, 2010

FDA approves Watson Pharmaceuticals' twice-yearly Trelstar formulation for prostate cancer

March 15, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...